New Website highlights the serious impact of Iron Deficiency
March 27, 2014 04:00 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
IronDeficiency.com - a...
Velphoro(R) (PA21) receives US FDA approval
November 28, 2013 01:41 ET
|
Vifor Pharma Ltd.
GLATTBRUGG, Switzerland, Nov. 28, 2013 (GLOBE NEWSWIRE) -- Velphoro® (PA21) receives US FDA approval for the treatment of hyperphosphatemia in Chronic Kidney Disease Patients on...
Velphoro® (PA21) receives US FDA approval
November 28, 2013 01:20 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Velphoro® (PA21) receives US...
Ferinject® reduces or delays requirement for alternative anaemia management compared with oral iron therapy
November 11, 2013 01:15 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Results from the...
Vifor Pharma and Zeria Pharmaceutical Co., Ltd. enter into an exclusive licensing agreement for Ferinject® in Japan
August 13, 2013 01:16 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Vifor Pharma, a company of the...
Injectafer® receives US FDA approval for the treatment of Iron Deficiency Anaemia
July 26, 2013 01:25 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Injectafer® has received US Food and...
L'étude FIND-CKD montre que Ferinject® réduit la nécessité d'un traitement alternatif de l'anémie
July 10, 2013 01:10 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
L'objectif de l'étude FIND-CKD était d'évaluer...
FIND-CKD-Studie zeigt, dass Ferinject® die Notwendigkeit für zusätzliche Anämietherapien verringert
July 10, 2013 01:10 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Ziel der FIND-CKD-Studie war, die optimale...
FIND-CKD study demonstrates that Ferinject® reduces need for alternative anaemia treatment
July 10, 2013 01:10 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
The FIND-CKD study was designed to investigate...
PDUFA action date for PA21 New Drug Application set by US FDA
April 15, 2013 01:18 ET
|
Vifor Pharma Ltd.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Following the submission of the New Drug Application...